Matthew W. Foehr sold Viking Therapeutics ($VKTX) shares once on the open market in the last year, totaling about $562,000, with the latest sale on January 2, 2026; this ranks 6,197th among 11,678 insiders averaging $8.6 million per seller. He also sold OmniAb ($OABIW) shares four times for $154,000 total, most recently on February 18, 2026, ranking 8,938th. Foehr made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | A | Stock Option | 1562500 | $0.00 | 1,562,500.0000 | 143,955,400 | 9999.99% | 1.09% |
| Feb. 18, 2026 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 58333 | $0.00 | 4,434,120.0000 | 143,955,400 | 1.33% | 0.04% |
| Feb. 18, 2026 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | S | Common Stock | 30843 | $1.71 | 4,403,277.0000 | 143,955,400 | 0.70% | 0.02% |
| Feb. 18, 2026 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Restricted Stock Units | 58333 | $0.00 | 189,585.0000 | 143,955,400 | 23.53% | 0.04% |
| Feb. 18, 2026 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | A | Restricted Stock Units | 156250 | $0.00 | 345,835.0000 | 143,955,400 | 82.42% | 0.11% |
| Feb. 16, 2026 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Restricted Stock Units | 36458 | $0.00 | 247,918.0000 | 143,955,400 | 12.82% | 0.03% |
| Feb. 16, 2026 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 36458 | $0.00 | 4,396,541.0000 | 143,955,400 | 0.84% | 0.03% |
| Feb. 17, 2026 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | S | Common Stock | 20754 | $1.70 | 4,375,787.0000 | 143,955,400 | 0.47% | 0.01% |
| Jan. 2, 2026 | Viking Therapeutics, Inc. | $VKTX | FOEHR MATTHEW W | Not found | M | Stock Option (Right to Buy) | 16000 | $0.00 | 0.0000 | 113,036,344 | 100.00% | 0.01% |
| Jan. 2, 2026 | Viking Therapeutics, Inc. | $VKTX | FOEHR MATTHEW W | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 113,036,344 | 9999.99% | 0.02% |
| Jan. 2, 2026 | Viking Therapeutics, Inc. | $VKTX | FOEHR MATTHEW W | Not found | M | Common Stock, par value $0.00001 per share | 16000 | $3.33 | 148,036.0000 | 113,036,344 | 12.12% | 0.01% |
| Jan. 2, 2026 | Viking Therapeutics, Inc. | $VKTX | FOEHR MATTHEW W | Not found | S | Common Stock, par value $0.00001 per share | 16000 | $35.11 | 132,036.0000 | 113,036,344 | 10.81% | 0.01% |
| Jan. 2, 2026 | Viking Therapeutics, Inc. | $VKTX | FOEHR MATTHEW W | Not found | A | Common Stock, par value $0.00001 per share | 3150 | $0.00 | 135,186.0000 | 113,036,344 | 2.39% | 0.00% |
| Dec. 7, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Restricted Stock Units | 26554 | $0.00 | 284,376.0000 | 143,955,400 | 8.54% | 0.02% |
| Dec. 8, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | S | Common Stock | 13666 | $1.96 | 4,360,083.0000 | 143,955,400 | 0.31% | 0.01% |
| Dec. 7, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 26554 | $0.00 | 4,373,749.0000 | 143,955,400 | 0.61% | 0.02% |
| Aug. 26, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | A | Common Stock | 540540 | $1.85 | 4,341,987.0000 | 122,134,941 | 14.22% | 0.44% |
| April 11, 2025 | Viking Therapeutics, Inc. | $VKTX | FOEHR MATTHEW W | Not found | M | Common Stock, par value $0.00001 per share | 20786 | $8.00 | 132,036.0000 | 112,247,809 | 18.68% | 0.02% |
| April 11, 2025 | Viking Therapeutics, Inc. | $VKTX | FOEHR MATTHEW W | Not found | M | Stock Option (Right to Buy) | 20786 | $0.00 | 0.0000 | 112,247,809 | 100.00% | 0.02% |
| April 7, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | S | Common Stock | 19382 | $2.00 | 3,796,236.0000 | 122,134,941 | 0.51% | 0.02% |
| April 7, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Restricted Stock Units | 36458 | $0.00 | 310,930.0000 | 122,134,941 | 10.49% | 0.03% |
| April 7, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 36458 | $0.00 | 3,815,618.0000 | 122,134,941 | 0.96% | 0.03% |
| Feb. 18, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | A | Stock Option (right to buy) | 1050000 | $0.00 | 1,050,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 16, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Restricted Stock Units | 36458 | $0.00 | 172,388.0000 | 0 | 17.46% | 0.00% |
| Feb. 15, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Restricted Stock Units | 26549 | $0.00 | 208,846.0000 | 0 | 11.28% | 0.00% |
| Feb. 19, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | S | Common Stock | 19522 | $3.67 | 3,779,160.0000 | 0 | 0.51% | 0.00% |
| Feb. 18, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | S | Common Stock | 13964 | $3.68 | 3,798,682.0000 | 0 | 0.37% | 0.00% |
| Feb. 16, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 36458 | $0.00 | 3,812,646.0000 | 0 | 0.97% | 0.00% |
| Feb. 15, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 26549 | $0.00 | 3,776,188.0000 | 0 | 0.71% | 0.00% |
| Feb. 18, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | A | Restricted Stock Units | 175000 | $0.00 | 347,388.0000 | 0 | 101.52% | 0.00% |
| Jan. 17, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | A | Common Stock | 77003 | $0.00 | 3,791,450.0000 | 0 | 2.07% | 0.00% |
| Jan. 21, 2025 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | S | Common Stock | 41811 | $3.24 | 3,749,639.0000 | 0 | 1.10% | 0.00% |
| Jan. 2, 2025 | Viking Therapeutics, Inc. | $VKTX | FOEHR MATTHEW W | Not found | A | Stock Option (Right to Buy) | 18800 | $0.00 | 18,800.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | S | Common Stock | 13634 | $4.13 | 3,714,447.0000 | 0 | 0.37% | 0.00% |
| Dec. 7, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Restricted Stock Units | 26555 | $0.00 | 235,395.0000 | 0 | 10.14% | 0.00% |
| Dec. 7, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 26555 | $0.00 | 3,728,081.0000 | 0 | 0.72% | 0.00% |
| Nov. 25, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 68360 | $3.75 | 3,698,600.0000 | 0 | 1.88% | 0.00% |
| Nov. 25, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Stock Option (right to buy) | 68360 | $0.00 | 396,484.0000 | 0 | 14.71% | 0.00% |
| Nov. 25, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 31074 | $3.68 | 3,630,240.0000 | 0 | 0.86% | 0.00% |
| Nov. 25, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Stock Option (right to buy) | 31074 | $0.00 | 155,371.0000 | 0 | 16.67% | 0.00% |
| June 27, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 41015 | $3.75 | 3,599,166.0000 | 0 | 1.15% | 0.00% |
| June 27, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 18644 | $3.68 | 3,558,151.0000 | 0 | 0.53% | 0.00% |
| June 27, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Stock Option (right to buy) | 18644 | $0.00 | 186,445.0000 | 0 | 9.09% | 0.00% |
| June 27, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Stock Option (right to buy) | 41015 | $0.00 | 464,844.0000 | 0 | 8.11% | 0.00% |
| May 24, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | P | Common Stock | 240000 | $4.42 | 3,536,665.0000 | 0 | 7.28% | 0.00% |
| Nov. 1, 2022 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | A | Common Stock | 1431618 | $0.00 | 3,296,665.0000 | 0 | 76.76% | 0.00% |
| April 7, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Restricted Stock Units | 36458 | $0.00 | 261,950.0000 | 0 | 12.22% | 0.00% |
| April 7, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 36458 | $0.00 | 3,188,874.0000 | 0 | 1.16% | 0.00% |
| April 7, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | F | Common Stock | 18477 | $5.31 | 3,170,397.0000 | 0 | 0.58% | 0.00% |
| March 27, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Stock Option (right to buy) | 93222 | $0.00 | 205,089.0000 | 0 | 31.25% | 0.00% |
| March 27, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 93222 | $3.68 | 3,002,025.0000 | 0 | 3.20% | 0.00% |
| March 27, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Common Stock | 150391 | $3.75 | 3,152,416.0000 | 0 | 5.01% | 0.00% |
| March 27, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | M | Stock Option (right to buy) | 150391 | $0.00 | 505,859.0000 | 0 | 22.92% | 0.00% |
| March 22, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | President and CEO | P | Common Stock | 225000 | $5.19 | 2,908,803.0000 | 0 | 8.38% | 0.00% |
| Feb. 15, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | Chief Executive Officer | M | Common Stock | 10770 | $0.00 | 2,676,164.0000 | 0 | 0.40% | 0.00% |
| Feb. 15, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | Chief Executive Officer | M | Restricted Stock Units | 10770 | $0.00 | 215,591.0000 | 0 | 4.76% | 0.00% |
| Feb. 15, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | Chief Executive Officer | F | Common Stock | 13460 | $5.54 | 2,683,803.0000 | 0 | 0.50% | 0.00% |
| Feb. 15, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | Chief Executive Officer | M | Common Stock | 26558 | $0.00 | 2,697,263.0000 | 0 | 0.99% | 0.00% |
| Feb. 15, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | Chief Executive Officer | F | Common Stock | 5459 | $5.54 | 2,670,705.0000 | 0 | 0.20% | 0.00% |
| Feb. 16, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | Chief Executive Officer | A | Stock Option (right to buy) | 656250 | $0.00 | 656,250.0000 | 0 | 9999.99% | 0.00% |
| Feb. 16, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | Chief Executive Officer | A | Restricted Stock Units | 109375 | $0.00 | 298,408.0000 | 0 | 57.86% | 0.00% |
| Feb. 15, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | Chief Executive Officer | M | Restricted Stock Units | 26558 | $0.00 | 189,033.0000 | 0 | 12.32% | 0.00% |
| Jan. 2, 2024 | Viking Therapeutics, Inc. | $VKTX | FOEHR MATTHEW W | Director | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | Chief Executive Officer | M | Restricted Stock Units | 33173 | $0.00 | 226,361.0000 | 0 | 12.78% | 0.00% |
| Jan. 2, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | Chief Executive Officer | M | Common Stock | 33173 | $0.00 | 2,678,615.0000 | 0 | 1.25% | 0.00% |
| Jan. 2, 2024 | OmniAb, Inc. | $OABI | FOEHR MATTHEW W | Chief Executive Officer | F | Common Stock | 13221 | $6.25 | 2,665,394.0000 | 0 | 0.49% | 0.00% |